Information Journal Paper
APA:
Copy. (2020). Ribavirin therapy for severe COVID-19: A retrospective cohort study. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 56(3), 0-0. SID. https://sid.ir/paper/996766/en
Vancouver:
Copy. Ribavirin therapy for severe COVID-19: A retrospective cohort study. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS[Internet]. 2020;56(3):0-0. Available from: https://sid.ir/paper/996766/en
IEEE:
Copy, “Ribavirin therapy for severe COVID-19: A retrospective cohort study,” INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, vol. 56, no. 3, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/996766/en